Optimizing Treatment of Staphylococcus aureus Bloodstream Infections Following Rapid Molecular Diagnostic Testing and an Antimicrobial Stewardship Program Intervention

Pending antibiotic susceptibility results, vancomycin is often used for bloodstream infections (BSIs) to ensure treatment of methicillin-resistant Staphylococcus aureus (MRSA). As rapid discrimination of methicillin-susceptible S. aureus (MSSA) from MRSA in BSIs could decrease vancomycin use and all...

Descripción completa

Detalles Bibliográficos
Autores principales: Al Sidairi, Hilal, Reid, Emma K., LeBlanc, Jason J., Sandila, Navjot, Head, Joline, Davis, Ian, Bonnar, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101007/
https://www.ncbi.nlm.nih.gov/pubmed/36790177
http://dx.doi.org/10.1128/spectrum.01648-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101007/
https://www.ncbi.nlm.nih.gov/pubmed/36790177
http://dx.doi.org/10.1128/spectrum.01648-22

Ejemplares similares